Reglodi D - Search Results

1

Agonistic behavior of PACAP6-38 on sensory nerve terminals and cytotrophoblast cells.

Reglodi D, Borzsei R, Bagoly T, Boronkai A, Racz B, Tamas A, Kiss P, Horvath G, Brubel R, Nemeth J, Toth G, Helyes Z. Reglodi D, et al. J Mol Neurosci. 2008 Nov;36(1-3):270-8. doi: 10.1007/s12031-008-9089-z. Epub 2008 Jul 8. J Mol Neurosci. 2008. PMID: 18607779

2

Comparative neuroprotective effects of preischemic PACAP and VIP administration in permanent occlusion of the middle cerebral artery in rats.

Tamás A, Reglõdi D, Szántó Z, Borsiczky B, Németh J, Lengvári I. Tamás A, et al. Among authors: reglodi d. Neuro Endocrinol Lett. 2002 Jun;23(3):249-54. Neuro Endocrinol Lett. 2002. PMID: 12080287

3

Comparative distribution of VIP in the central nervous system of various species measured by a new radioimmunoassay.

Németh J, Jakab B, Reglodi D, Lubics A, Józsa R, Hollósy T, Tamás A, Lengvári I, Görcs T, Szolcsányi J. Németh J, et al. Among authors: reglodi d. Regul Pept. 2002 Nov 15;109(1-3):3-7. doi: 10.1016/s0167-0115(02)00165-9. Regul Pept. 2002. PMID: 12409208

4

Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia.

Reglodi D, Tamás A, Somogyvári-Vigh A, Szántó Z, Kertes E, Lénárd L, Arimura A, Lengvári I. Reglodi D, et al. Peptides. 2002 Dec;23(12):2227-34. doi: 10.1016/s0196-9781(02)00262-0. Peptides. 2002. PMID: 12535703

5

Examination of sensorimotor performance following middle cerebral artery occlusion in rats.

Reglodi D, Tamás A, Lengvári I. Reglodi D, et al. Brain Res Bull. 2003 Feb 15;59(6):459-66. doi: 10.1016/s0361-9230(02)00962-0. Brain Res Bull. 2003. PMID: 12576143

6

The effects of PACAP and PACAP antagonist on the neurobehavioral development of newborn rats.

Reglodi D, Kiss P, Tamás A, Lengvári I. Reglodi D, et al. Behav Brain Res. 2003 Mar 18;140(1-2):131-9. doi: 10.1016/s0166-4328(02)00289-9. Behav Brain Res. 2003. PMID: 12644286

7

The effect of PACAP on rhythmic melatonin release of avian pineals.

Csernus V, Józsa R, Reglodi D, Hollósy T, Somogyvári-Vigh A, Arimura A. Csernus V, et al. Among authors: reglodi d. Gen Comp Endocrinol. 2004 Jan 1;135(1):62-9. doi: 10.1016/s0016-6480(03)00284-3. Gen Comp Endocrinol. 2004. PMID: 14644645

8

Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease.

Reglodi D, Lubics A, Tamás A, Szalontay L, Lengvári I. Reglodi D, et al. Behav Brain Res. 2004 May 5;151(1-2):303-12. doi: 10.1016/j.bbr.2003.09.007. Behav Brain Res. 2004. PMID: 15084446

9

Effects of PACAP on in vitro and in vivo neuronal cell death, platelet aggregation, and production of reactive oxygen radicals.

Reglodi D, Fábián Z, Tamás A, Lubics A, Szeberényi J, Alexy T, Tóth K, Márton Z, Borsiczky B, Rõth E, Szalontay L, Lengvári I. Reglodi D, et al. Regul Pept. 2004 Dec 15;123(1-3):51-9. doi: 10.1016/j.regpep.2004.05.012. Regul Pept. 2004. PMID: 15518893

10

Effects of pituitary adenylate cyclase activating polypeptide in a rat model of traumatic brain injury.

Farkas O, Tamás A, Zsombok A, Reglodi D, Pál J, Büki A, Lengvári I, Povlishock JT, Dóczi T. Farkas O, et al. Among authors: reglodi d. Regul Pept. 2004 Dec 15;123(1-3):69-75. doi: 10.1016/j.regpep.2004.05.014. Regul Pept. 2004. PMID: 15518895

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

301 results

Search Page

Filters